Lexicon Pharmaceuticals (LXRX) Revenue (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Lexicon Pharmaceuticals (LXRX) revenue is $70M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Lexicon Pharmaceuticals (LXRX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1028.69% |
| 5 Years TTM | +24.37% |
| 10 Years TTM | -6.79% |
| All Time TTM | +27.47% |
Annual Revenue change of Lexicon Pharmaceuticals (LXRX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $21M | -57.63% |
| 2025 | $50M | +730.00% |
| 2024 | $6M | +440.54% |
| 2023 | $1.11M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | -100.00% |
| 2020 | $23M | -27.62% |
| 2019 | $32M | +21.63% |
| 2018 | $27M | +67.28% |
| 2017 | $16M | N/A |
| 2016 | $0 | -100.00% |
| 2015 | $130M | +468.97% |
| 2014 | $23M | +929.28% |
| 2013 | $2.22M | +103.67% |
| 2012 | $1.09M | -41.08% |
| 2011 | $1.85M | -62.32% |
| 2010 | $4.91M | -54.11% |
| 2009 | $11M | N/A |
Comparison Lexicon Pharmaceuticals (LXRX) five years revenue CAGR with competitors
Lexicon Pharmaceuticals (LXRX) five years revenue CAGR is 24.38%.